מונטהלוקאסט אינובמד 5 מ"ג

Šalis: Izraelis

kalba: hebrajų

Šaltinis: Ministry of Health

Veiklioji medžiaga:

MONTELUKAST AS SODIUM 5 MG

Prieinama:

INOVAMED LTD

ATC kodas:

R03DC03

Vaisto forma:

CHEWABLE TABLETS

Vartojimo būdas:

PER OS

Pagaminta:

SYNTHON B.V., NETHERLANDS

Farmakoterapinė grupė:

MONTELUKAST

Terapinės indikacijos:

Montelukast Inovamed is indicated in pediatric patients 6 to 14 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.Montelukast Inovamed is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast Inovamed and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast Inovamed is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 6 to 14 years of age.

Leidimo data:

2012-01-01